Epidemiology of carbapenem resistant acinetobacter baumannii in large multidisciplinary hospital
2-10 % no visām gram negatīvo baktēriju infekcijām Eiropas un Amerikas Savienoto Valstu intensīvās terapijas nodaļās ir Acinetobacter baumannii celmu izraisītas.
Karlsone, Aija
core
Characterization of carbapenem-resistant Acinetobacter baumannii in Shanghai and Hong Kong [PDF]
Chun Mei, Ying +3 more
openaire +2 more sources
Integrated experimental and computational evaluation of Anagallis foemina derived terpenoids against carbapenem resistant Acinetobacter baumannii. [PDF]
Afzal M +7 more
europepmc +1 more source
Phage vB_AbaM_MU1 for biocontrol of carbapenem-resistant Acinetobacter baumannii (CRAB) isolated from wound infection. [PDF]
Sabry H +4 more
europepmc +1 more source
Risk factors for carbapenem-resistant Acinetobacter baumannii infection in children and A. baumannii-related mortality in the PICU: a retrospective study in Guangxi, China. [PDF]
Liu M, Huang Z, Huang L, Yan C.
europepmc +1 more source
Risk factors, prognostic impact, and antimicrobial susceptibility profiles of carbapenem-resistant Acinetobacter baumannii bloodstream infections: a retrospective cohort study. [PDF]
Pu N, Li K.
europepmc +1 more source
What is already known about this topic? Carbapenem-resistant Acinetobacter Baumannii (CRAB) causes health care\u2013associated infections that are challenging to contain and often linked to infection Prevention and control (IPC) breaches.What is added by
core
Successful Use of Sulbactam-Durlobactam in Treating Carbapenem-Resistant Acinetobacter baumannii Pneumonia and Sepsis After Liver Transplantation: A Case Report. [PDF]
Xiong HF +9 more
europepmc +1 more source

